Boston Partners
CCRN

Boston Partners’s Cross Country Healthcare CCRN Stock Holding History

Boston Partners’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$944K Sell
71,496
-2,474,088
-97% -$29.3M ﹤0.01% 679
2026
Q1 		$23.9M Buy
2,545,584
+1,753,790
+221% +$15.7M 0.03% 348
2025
Q4 		$6.41M Buy
+791,794
New +$8.65M 0.01% 455
2024
Q4 		– Sell
-200,615
Closed -$2.7M – 719
2024
Q3 		$2.7M Buy
200,615
+73,277
+58% +$1.08M ﹤0.01% 483
2024
Q2 		$1.76M Sell
127,338
-6,773
-5% -$107K ﹤0.01% 525
2024
Q1 		$2.51M Buy
+134,111
New +$2.68M ﹤0.01% 482
2019
Q4 		– Sell
-67,399
Closed -$694K – 710
2019
Q3 		$694K Sell
67,399
-26,131
-28% -$257K ﹤0.01% 611
2019
Q2 		$877K Buy
+93,530
New +$720K ﹤0.01% 622
2018
Q3 		– Sell
-137,600
Closed -$1.55M – 716
2018
Q2 		$1.55M Buy
137,600
+61,000
+80% +$727K ﹤0.01% 696
2018
Q1 		$851K Buy
+76,600
New +$960K ﹤0.01% 705
2017
Q4 		– Sell
-61,370
Closed -$873K – 753
2017
Q3 		$873K Buy
61,370
+26,100
+74% +$327K ﹤0.01% 725
2017
Q2 		$455K Sell
35,270
-84,700
-71% -$1.09M ﹤0.01% 721
2017
Q1 		$1.72M Sell
119,970
-26,630
-18% -$392K ﹤0.01% 671
2016
Q4 		$2.29M Sell
146,600
-84,570
-37% -$1.16M ﹤0.01% 658
2016
Q3 		$2.72M Buy
231,170
+53,940
+30% +$710K ﹤0.01% 610
2016
Q2 		$2.47M Buy
177,230
+33,700
+23% +$447K ﹤0.01% 607
2016
Q1 		$1.67M Buy
+143,530
New +$1.82M ﹤0.01% 642
2015
Q4 		– Sell
-13,000
Closed -$177K – 738
2015
Q3 		$177K Sell
13,000
-51,767
-80% -$703K ﹤0.01% 697
2015
Q2 		$821K Buy
+64,767
New +$734K ﹤0.01% 672
2015
Q1 		– Sell
-298,850
Closed -$3.73M – 705
2014
Q4 		$3.73M Sell
298,850
-688,150
-70% -$7.03M 0.01% 575
2014
Q3 		$9.17M Buy
987,000
+9,377
+1% +$71.9K 0.01% 412
2014
Q2 		$6.37M Buy
977,623
+555,793
+132% +$3.67M 0.01% 475
2014
Q1 		$3.4M Sell
421,830
-71,400
-14% -$702K 0.01% 573
2013
Q4 		$4.92M Sell
493,230
-32,324
-6% -$224K 0.01% 517
2013
Q3 		$3.19M Buy
+525,554
New +$3.01M 0.01% 557

Other funds holding CCRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.84B AUM 38.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Boston Partners's CCRN Position: Q2 2026 in Review

Boston Partners reduced its Cross Country Healthcare (CCRN) stake by 97% in Q2 2026, selling an estimated $29.3M and leaving 71,496 shares worth $944K. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Boston Partners first reported a position in CCRN in Q3 2013 and has held it in 25 quarters since. The position peaked at $23.9M in Q1 2026. 151 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • Boston Partners held 71,496 shares of Cross Country Healthcare worth $944K as of Q2 2026.
  • Boston Partners sold 2,474,088 Cross Country Healthcare shares in Q2 2026, an estimated $29.3M.
  • Cross Country Healthcare made up ﹤0.01% of Boston Partners's portfolio in Q2 2026, its #679 holding.
  • Boston Partners first reported a position in Cross Country Healthcare in Q3 2013 and has held it in 25 quarters since.
  • Boston Partners's Cross Country Healthcare position peaked at $23.9M in Q1 2026.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.